Thomas Hentrich

ResearcherID Loop profile Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 4

Top Topics

Induced Pluripotent Stem Cells

Top Venues

Journal of clinical medicine

Disease models & mechanisms

Universitätsklinikum Tübingen

University of British Columbia (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Universitätsklinikum Tübingen

Germany

Bioinformatician in neuro-transcriptomics / -epigenomics; PostDoc :: Medical Genetics and Applied Genomics

Education History

University of British Columbia

Canada

PHD :: Computer Science

Publications

Sara Y Brucker, Thomas Hentrich, Julia M Schulze-Hentrich, Martin Pietzsch, Noel Wajngarten, Anjali Ralhan Singh, Katharina Rall, André Koch
Endometrial organoids derived from Mayer-Rokitansky-Küster-Hauser syndrome patients provide insights into disease-causing pathways. Disease models & mechanisms 15 (5) (2022)
Rebecca Buchert, Elisabeth Schenk, Thomas Hentrich, Nico Weber, Kristin Katharina Rall, Marc Sturm, Oliver Kohlbacher, André Koch, Olaf H Rieß, Sara Yvonne Brucker, Julia M Schulze-Hentrich
Genome Sequencing and Transcriptome Profiling in Twins Discordant for Mayer-Rokitansky-Küster-Hauser Syndrome. Journal of clinical medicine 11 (19) (2022)
Kathy-Ann Secker, Lukas Bruns, Hildegard Keppeler, Johan Jeong, Thomas Hentrich, Julia M Schulze-Hentrich, Barbara Mankel, Falko Fend, Dominik Schneidawind, Corina Schneidawind
Only Hematopoietic Stem and Progenitor Cells from Cord Blood Are Susceptible to Malignant Transformation by MLL-AF4 Translocations. Cancers 12 (6) (2020)
Kathy-Ann Secker, Bianca Bloechl, Hildegard Keppeler, Silke Duerr-Stoerzer, Hannes Schmid, Dominik Schneidawind, Johan Jeong, Thomas Hentrich, Julia M Schulze-Hentrich, Corina Schneidawind
MAT2A as Key Regulator and Therapeutic Target in MLLr Leukemogenesis. Cancers 12 (5) (2020)